CLYM logo

CLYM
Climb Bio Inc.

370
Mkt Cap
$602.38M
Volume
408,714.00
52W High
$12.48
52W Low
$1.16
PE Ratio
-13.51
CLYM Fundamentals
Price
$10.88
Prev Close
$10.52
Open
$10.57
50D MA
$8.64
Beta
1.14
Avg. Volume
728,534.93
EPS (Annual)
-$0.8826
P/B
3.39
Rev/Employee
$0.00
$170.71
Loading...
Loading...
News
all
press releases
Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade
Climb Bio (NASDAQ:CLYM) Reaches New 52-Week High Following Analyst Upgrade...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
Climb Bio (NASDAQ:CLYM) Stock Price Expected to Rise, BTIG Research Analyst Says
BTIG Research boosted their price objective on shares of Climb Bio from $8.00 to $19.00 and gave the company a 'buy' rating in a report on Wednesday...
MarketBeat·15d ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next?
Climb Bio (NASDAQ:CLYM) Trading 10.8% Higher - What's Next...
MarketBeat·16d ago
News Placeholder
Climb Bio Spotlights Budoprutug CD19 Strategy, Sets Up 2026 Data Readouts in pMN, ITP and SLE
Climb Bio (NASDAQ:CLYM) used an investor R&D spotlight event to outline its strategy around CD19-targeted B-cell depletion and to provide updates on development plans and timelines for its lead...
MarketBeat·16d ago
News Placeholder
Climb Bio, Inc. $CLYM Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its stake in Climb Bio, Inc. (NASDAQ:CLYM - Free Report) by 89.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·29d ago
News Placeholder
Climb Bio, Inc. (NASDAQ:CLYM) Receives Average Recommendation of "Buy" from Brokerages
Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have been assigned an average recommendation of "Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. One...
MarketBeat·29d ago
News Placeholder
Oppenheimer Raises Climb Bio (NASDAQ:CLYM) Price Target to $18.00
Oppenheimer upped their price target on shares of Climb Bio from $10.00 to $18.00 and gave the stock an "outperform" rating in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Upgraded to "Strong-Buy" at Mizuho
Mizuho raised Climb Bio to a "strong-buy" rating in a research report on Wednesday...
MarketBeat·1mo ago
News Placeholder
Climb Bio's (CLYM) "Buy" Rating Reaffirmed at BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Climb Bio in a research report on Wednesday...
MarketBeat·1mo ago
News Placeholder
Climb Bio, Inc. (NASDAQ:CLYM) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have earned an average rating of "Buy" from the eleven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a buy rating and three have issued a strong buy rati...
MarketBeat·2mo ago
<
1
2
...
>

Latest CLYM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.